General Mills CapEx decreased by 28.7% to $102.40M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.4%, from $103.90M to $102.40M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 4.2% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $184.40M | $104.00M | $120.30M | $126.30M | $218.10M | $90.90M | $135.80M | $124.60M | $338.20M | $141.70M | $152.20M | $191.70M | $288.50M | $140.30M | $160.90M | $103.90M | $220.20M | $109.50M | $143.60M | $102.40M |
| QoQ Change | — | -43.6% | +15.7% | +5.0% | +72.7% | -58.3% | +49.4% | -8.2% | +171.4% | -58.1% | +7.4% | +26.0% | +50.5% | -51.4% | +14.7% | -35.4% | +111.9% | -50.3% | +31.1% | -28.7% |
| YoY Change | — | — | — | — | +18.3% | -12.6% | +12.9% | -1.3% | +55.1% | +55.9% | +12.1% | +53.9% | -14.7% | -1.0% | +5.7% | -45.8% | -23.7% | -22.0% | -10.8% | -1.4% |